Complete clinical response to neoadjuvant chemoradiotherapy in patients with rectal cancer: Opinions of British and Irish specialists

Colorectal Disease

Volumn 12, Issue 4, 2010, Pages 327-333

  Wynn, G R ^a   Bhasin, N ^b   Macklin, C P ^b   George, M L ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b Dewsbury and District Hospital ^*  (United Kingdom)

Author keywords

Chemoradiotherapy; Complete response; Rectal cancer

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CONSERVATIVE TREATMENT; HUMAN; IMAGING; NORMAL HUMAN; PRIORITY JOURNAL; QUESTIONNAIRE; RECTUM CANCER; SURGEON; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR CELL;

ATTITUDE OF HEALTH PERSONNEL; CHEMOTHERAPY, ADJUVANT; COLORECTAL SURGERY; DATA COLLECTION; FEMALE; GREAT BRITAIN; HUMANS; IRELAND; MALE; NEOADJUVANT THERAPY; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN-PATIENT RELATIONS; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; REMISSION INDUCTION;

EID: 77954377770     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2009.01962.x     Document Type: Article

References (30)

1. Heald RJ, Morannumber> BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal Cancer: the Basingstoke experience of total mesorectal excision 1978-1997. Arch Surg 1998, 133:894-9.
2. Melton GB, Lavely WC, Jacene HA, Schulick RD, Choti MA, Wahl RL, Gearhart SL. Efficacy of preoperative combined 18-flurodeoxyglucose positron emission tomography and computed tomography for assessing primary rectal cancer response to neoadjuvant therapy. J Gastrointest Surg 2007, 11:961-9.
3. Brown G, Radcliffe AG, Newcombe RG, Dallimore NS, Bourne MW, Williams GT. Preoperative assessment of prognostic factors in rectal cancer using high resolution magnetic resonance imaging. Br J Surg 2003, 90:355-64.
4. Kapiteijn E, Marijnen CA, Nagtegaal ID. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001, 345:638-46.
5. Balch GC, De Meo A, Guillem JG. Modern management of rectal cancer: a 2006 update. World J Gastroenterol 2006, 12:3186-95.
6. Glynne-Jones R, Harrison M. Locally advanced rectal cancer: what is the evidence for induction chemoradiation? Oncologist 2007, 12:1309-18.
7. Chessin DB, Enker W, Cohen AM, Paty PB, Weiser MR, Saltz L, Minsky BD, Wong WD, Guillem JG. Complications after preoperative combined modality therapy and radical resection of locally advanced rectal cancer: a 14 year experience from a speciality service. J Am Coll Surg 2005, 200:876-82.
8. Hendren SK, O'Connor BI, Liu M, Asano T, Cohen Z, Swallow CJ, Macrae HM, Gryfe R, McLeod RS. Prevalence of make and female sexual dysfunction is high following surgery for rectal cancer. Ann Surg 2005, 242:212-23.
9. Neal DE, Williams NS, Johnston D. A prospective study of bladder function before and after sphincter-saving resections for low carcinoma of the rectum. Br J Urol 1981, 53:558-64.
10. Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U, Silva Sousa AH, Campos FG, Kiss DR, Gama-Rodrigues J. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 2004, 240:711-7.
11. Bossema E, Stiggelbout A, Baas-Thijssen M, van de Velde C, Marijnen C. Patients' preferences for low rectal cancer surgery. Eur J Surg Oncol 2008, 34:42-8.
12. Rutten H, Sebag-Montefiore D, Glynne-Jones R, Rullier E, Peeters M, Brown G, van Cutsem E, Ricci S, van de Velde C, Quirke P. Capecitabine, oxaliplatin, radiotherapy, and excision (CORE) in patients with MRI-defined locally advanced rectal adenocarcinoma: results of an international mulitcentre phase II study. Proc Am Soc Clin Oncol 2006, 24:3528.
13. Glynne-Jones R, Anyamene N. Just how useful an endpoint is complete pathological response after neoadjuvant chemoradiation in rectal cancer? Int J Radiat Oncol Biol Phys 2006, 66:319-20.
14. Guillem JG, Chessin DB, Shia J. Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point. J Clin Oncol 2005, 23:3475-9.
15. Chau I, Brown G, Cunningham D. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J Clin Oncol 2006, 24:668-74.
16. Maretto I, Pomerri F, Pucciarelli S, Mescoli C, Belluco E, Burzi S, Rugge M, Muzzio PC, Nitti D. The potential of restaging in the prediction of pathologic response after preoperative chemoradiotherapy for rectal cancer. Ann Surg Oncol 2007, 14:455-61.
17. Chen CC, Lee RC, Lin JK, Wang LW, Yang SH. How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy? Dis Colon Rectum 2005, 48:722-8.
18. Arulampalam TH, Costa DC, Loizidou M, Visvikis D, Ell PJ, Taylor I. Positron emission tomography and colorectal cancer. Br J Surg 2001, 88:176-89.
19. Guillem JG, Moore HG, Akhurst T, Klimstra DS, Ruo L, Mazumdar M, Minsky BD, Saltz L, Wong WD, Larson S. Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer. J Am Coll Surg 2004, 199:1-7.
20. Capirci C, Rampin L, Erba PA. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy. Eur J Nucl Med Mol Imaging 2007, 34:1583-93.
21. Konski A, Li T, Sigurdson E, Cohen SJ, Small W, Spies S, Yu JQ, Wahl A, Stryker S, Meropol NJ. Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation. Int J Radiat Oncol Biol Phys 2009, 74:55-9.
22. Pucciarelli S, Capirci C, Emanuele U, Toppan P, Friso ML, Pennelli GM, Crepaldi G, Pasetto L, Nitti D, Lise M. Relationship between pathologic T-stage and nodal metastasis after preoperative chemoradiotherapy for locally advanced rectal cancer. Ann Surg Oncol 2005, 12:111-6.
23. Coco C, Manno A, Mattana C, Verbo A, Rizzo G, Valentini V, Gambacorta MA, Vecchio FM, D'Ugo D. The role of local excision in rectal cancer after complete response to neoadjuvant treatment. Surg Oncol 2007, 16(Suppl. 1):S101-4.
24. O'Neill BDP, Brown G, Heald RJ, Cunningham D, Tait DM. Non-operative treatment after neo-adjuvant chemoradiotherapy for rectal cancer. Lancet Oncol 2007, 8:625-33.
25. Francois Y, Nemoz CJ, Baulieux J, Vignal J, Grandjean JP, Partensky C, Souquet JC, Adeleine P, Gerard JP. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol 1999, 17:2396.
26. Habr-Gama A, Perez RO, Proscurshim I, Nunes Dos Santos RM, Kiss D, Gama-Rodrigues J, Cecconello I. Interval between surgery and neoadjuvant chemoradiation therapy for distal rectal cancer: does delay to surgery have an impact on outcome? Int J Radiat Oncol Biol Phys 2008, 71:1181-8.
27. Kerr SF, Norton S, Glynne-Jones R. Delaying surgery after neoadjuvant chemoradiotherapy for rectal cancer may reduce postoperative morbidity without compromising prognosis. Br J Surg 2008, 95:1534-40.
28. Wong RK, Tandan V, De Silva S, Figueredo A. Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma. Cochrane Database Syst Rev 2007, 18:CD002102.
29. Capirci C, Valentini V, Cionini L. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. Int J Radiat Oncol Biol Phys 2008, 72:99-107.
30. Habr-Gama A, Perez RO, Proscurshim I, Campos FG, Nadalin W, Kiss D, Gama-Rodrigues J. Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J Gastrointest Surg 2006, 10:1319-28.